Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome

Endocrine ◽  
2018 ◽  
Vol 61 (2) ◽  
pp. 327-335 ◽  
Author(s):  
N. Tahani ◽  
L. Nieddu ◽  
G. Prossomariti ◽  
M. Spaziani ◽  
S. Granato ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Klinefelter Syndrome ◽  
Term Effect ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy ◽  
Long Term Effect

scholarly journals Testosterone Replacement Therapy: Long-Term Safety and Efficacy

2017 ◽  
Vol 35 (2) ◽  
pp. 65 ◽  
Author(s):  
Giovanni Corona ◽  
Alessandra Sforza ◽  
Mario Maggi
Keyword(s):  
Replacement Therapy ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy ◽  
Safety And Efficacy

scholarly journals Testosterone Replacement Therapy and the Risk of Hypoglycemia

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Analía Verónica Yamaguchi ◽  
Pablo René Costanzo ◽  
Verónica Andrea Peuchot ◽  
Pablo Knoblovits
Keyword(s):  
Type 2 Diabetes ◽  
Drug Interaction ◽  
Replacement Therapy ◽  
Metabolic Control ◽  
Klinefelter Syndrome ◽  
Testosterone Replacement ◽  
Hypoglycemic Agents ◽  
Testosterone Replacement Therapy ◽  
History Of

We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control. When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone injection. We highlight this not widely reported drug interaction between hypoglycemic agents and testosterone.

Sign in / Sign up

Export Citation Format

Share Document